Mark Becker

889 total citations
10 papers, 520 citations indexed

About

Mark Becker is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mark Becker has authored 10 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Mark Becker's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Mark Becker is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Mark Becker collaborates with scholars based in United States, United Kingdom and Switzerland. Mark Becker's co-authors include Margaret A. Chesney, Christos J. Petropoulos, Laura Smeaton, Carla Pettinelli, Charles van der Horst, Robert Delapenha, Nicholas S. Hellmann, Victor De Gruttola, Margaret A. Fischl and Martin Hirsch and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Mark Becker

10 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Becker United States 9 453 399 87 53 24 10 520
Elisabetta Chiesa Italy 11 306 0.7× 242 0.6× 96 1.1× 63 1.2× 7 0.3× 17 351
Frank-D. Goebel Germany 5 260 0.6× 230 0.6× 114 1.3× 74 1.4× 10 0.4× 7 348
S.F.L. van Lelyveld Netherlands 13 255 0.6× 234 0.6× 111 1.3× 107 2.0× 18 0.8× 28 395
Ian McGowan United States 6 464 1.0× 362 0.9× 46 0.5× 108 2.0× 17 0.7× 11 492
C Abeli Italy 7 229 0.5× 177 0.4× 59 0.7× 45 0.8× 35 1.5× 9 275
Gianmaria Baldin Italy 13 387 0.9× 294 0.7× 124 1.4× 84 1.6× 28 1.2× 50 457
Eugénio Teófilo Portugal 9 254 0.6× 178 0.4× 63 0.7× 74 1.4× 17 0.7× 22 319
Maria Pia De Pasquale Italy 9 284 0.6× 231 0.6× 28 0.3× 66 1.2× 31 1.3× 12 343
Fabienne Caby France 9 232 0.5× 231 0.6× 123 1.4× 92 1.7× 16 0.7× 26 365
Diane Bollens France 10 392 0.9× 279 0.7× 74 0.9× 171 3.2× 15 0.6× 18 476

Countries citing papers authored by Mark Becker

Since Specialization
Citations

This map shows the geographic impact of Mark Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Becker more than expected).

Fields of papers citing papers by Mark Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Becker. The network helps show where Mark Becker may publish in the future.

Co-authorship network of co-authors of Mark Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Becker. A scholar is included among the top collaborators of Mark Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Becker. Mark Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Benator, Debra, Marc Weiner, William J. Burman, et al.. (2007). Clinical Evaluation of the Nelfinavir‐Rifabutin Interaction in Patients with Tuberculosis and Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(6). 793–800. 10 indexed citations
2.
Stocker, Hartmut, Christian Herzmann, Andrew Hill, et al.. (2007). Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration. Journal of Antimicrobial Chemotherapy. 59(3). 560–564. 4 indexed citations
3.
Damle, Bharat, et al.. (2006). Pharmacokinetics of Nelfinavir in Subjects With Hepatic Impairment. The Journal of Clinical Pharmacology. 46(11). 1241–1249. 10 indexed citations
4.
Eßer, Stefan, Hartmut Stocker, Birgit Ross, et al.. (2005). The Steady-State Pharmacokinetics of Nelfinavir in Combination with Tenofovir in HIV-Infected Patients. Antiviral Therapy. 10(2). 349–355. 9 indexed citations
5.
Robbins, Gregory K., Victor De Gruttola, Robert W. Shafer, et al.. (2003). Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection. New England Journal of Medicine. 349(24). 2293–2303. 272 indexed citations
6.
Donahue, John P., David W. Dowdy, Todd Hulgan, et al.. (2003). Effects of nelfinavir and its M8 metabolite on lymphocyte P‐glycoprotein activity during antiretroviral therapy. Clinical Pharmacology & Therapeutics. 73(1). 78–86. 22 indexed citations
7.
Capparelli, Edmund V., John L. Sullivan, Lynne Mofenson, et al.. (2001). Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. The Pediatric Infectious Disease Journal. 20(8). 746–751. 30 indexed citations
8.
Walmsley, Sharon, Mark Becker, Min Zhang, Atul Humar, & P. Richard Harrigan. (2001). Predictors of Virological Response in HIV-Infected Patients to Salvage Antiretroviral Therapy that Includes Nelfinavir. Antiviral Therapy. 6(1). 47–54. 13 indexed citations
9.
10.
Ormerod, L. David, Peter N.R. Heseltine, Eduardo C. Alfonso, et al.. (1989). GENTAMICIN-RESISTANT PSEUDOMONAL INFECTION. Cornea. 8(3). 195???199–195???199. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabetta Chiesa Breakdown of academic impact, for papers by Frank-D. Goebel Breakdown of academic impact, for papers by S.F.L. van Lelyveld Breakdown of academic impact, for papers by Ian McGowan Breakdown of academic impact, for papers by C Abeli Breakdown of academic impact, for papers by Gianmaria Baldin Breakdown of academic impact, for papers by Eugénio Teófilo Breakdown of academic impact, for papers by Maria Pia De Pasquale Breakdown of academic impact, for papers by Fabienne Caby Breakdown of academic impact, for papers by Diane Bollens
Rankless by CCL
2026